NLRP3-inflammasome inhibition by MCC950 attenuates cardiac and pulmonary artery remodelling in heart failure with preserved ejection fractionXiaocheng Cheng, Dongying Zhang, Hanru Zhao et al.|Life Sciences|2023Cited by 33